As of 2025-07-11, the Relative Valuation of Cara Therapeutics Inc (CARA) is (303.55) USD. This relative valuation is based on P/E multiples. With the latest stock price at 5.32 USD, the upside of Cara Therapeutics Inc based on Relative Valuation is -5805.8%.
The range of the Relative Valuation is (304.56) - (288.43) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.9x - 18.6x | 18.4x |
| Forward P/E multiples | 19.6x - 22.4x | 20.8x |
| Fair Price | (304.56) - (288.43) | (303.55) |
| Upside | -5824.8% - -5521.6% | -5805.8% |
| Date | P/E |
| 2025-05-09 | -1.65 |
| 2025-05-08 | -1.68 |
| 2025-05-07 | -1.68 |
| 2025-05-06 | -1.69 |
| 2025-05-05 | -1.79 |
| 2025-05-02 | -1.72 |
| 2025-05-01 | -1.64 |
| 2025-04-30 | -1.61 |
| 2025-04-29 | -1.48 |
| 2025-04-28 | -1.36 |
| 2025-04-25 | -1.22 |
| 2025-04-24 | -1.15 |
| 2025-04-23 | -1.19 |
| 2025-04-22 | -1.26 |
| 2025-04-21 | -1.13 |
| 2025-04-17 | -1.10 |
| 2025-04-16 | -1.18 |
| 2025-04-15 | -1.03 |
| 2025-04-14 | -1.07 |
| 2025-04-11 | -0.95 |